Cases of myocarditis have been reported following mRNA COVID-19 vaccination, but they are rare and usually mild. Yet, a viral video distorts news reports to falsely claim 850 people died in Monterrey, Mexico, in June due to myocarditis. The figure comes from a false report of heat-related deaths.
A Swiss study found that after a COVID-19 booster, less than 3% of people briefly had a slightly elevated blood level of a protein that can be a marker of heart injury. No one in the study had any serious heart damage, and other experts say the findings are unlikely to be clinically significant. Viral posts, however, are spinning the results to falsely claim that the study shows the vaccine’s risks are “off the scale.”
Buffalo Bills player Damar Hamlin collapsed on the field and suffered a cardiac arrest moments after taking a hit to his chest during a tackle. While it’s not yet known why his heart stopped, some experts say his condition is most likely due to a heart rhythm problem as a result of that impact. Still, people on social media have baselessly speculated that it was caused by a COVID-19 vaccine.
The state of Florida recently announced that it was no longer recommending that younger males receive mRNA COVID-19 vaccines, based on an unpublished analysis that purportedly found an increased risk of cardiac-related death following vaccination. But experts who specialize in the unique method used in the analysis say it was not properly done — and even if it had been, the findings would not mean that individuals should not get vaccinated.
Studies have found that COVID-19 increases the risk for heart complications, and that the benefits of COVID-19 vaccination outweigh the risks for males and females in all age groups. Social media posts, however, have misinterpreted and publicized a criticized study that claims to have identified a correlation between emergency calls for cardiac events and the vaccination rate in Israel.
Rare cases of myocarditis have been reported following the mRNA COVID-19 vaccines, particularly among young males after a second dose. Most cases resolve quickly without the need for advanced therapies, although research on any potential long-term effects is ongoing. Nonetheless, the benefits of vaccination outweigh the risks in all populations, even in young males.